Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Structural Alterations of the Social Brain: A Comparison between Schizophrenia and Autism

  • Daniel Radeloff ,

    daniel.radeloff@kgu.de

    Affiliation Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Frankfurt/Main,Germany

  • Angela Ciaramidaro,

    Affiliation Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Frankfurt/Main,Germany

  • Michael Siniatchkin,

    Affiliation Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Frankfurt/Main,Germany

  • Daniela Hainz,

    Affiliation Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Frankfurt/Main,Germany

  • Sabine Schlitt,

    Affiliation Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Frankfurt/Main,Germany

  • Bernhard Weber,

    Affiliations Department of Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe Universität Frankfurt/Main, Frankfurt/Main, Germany, Psychiatric University Clinics, University of Basel, Basel, Switzerland

  • Fritz Poustka,

    Affiliation Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Frankfurt/Main,Germany

  • Sven Bölte,

    Affiliations Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Frankfurt/Main,Germany, Department of Women’s and Children’s Health, Center of Neurodevelopmental Disorders at Karolinska Institutet (KIND), Stockholm, Sweden

  • Henrik Walter,

    Affiliations Department of Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe Universität Frankfurt/Main, Frankfurt/Main, Germany, Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany

  • Christine Margarete Freitag

    Affiliation Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Frankfurt/Main,Germany

Abstract

Autism spectrum disorder and schizophrenia share a substantial number of etiologic and phenotypic characteristics. Still, no direct comparison of both disorders has been performed to identify differences and commonalities in brain structure. In this voxel based morphometry study, 34 patients with autism spectrum disorder, 21 patients with schizophrenia and 26 typically developed control subjects were included to identify global and regional brain volume alterations. No global gray matter or white matter differences were found between groups. In regional data, patients with autism spectrum disorder compared to typically developed control subjects showed smaller gray matter volume in the amygdala, insula, and anterior medial prefrontal cortex. Compared to patients with schizophrenia, patients with autism spectrum disorder displayed smaller gray matter volume in the left insula. Disorder specific positive correlations were found between mentalizing ability and left amygdala volume in autism spectrum disorder, and hallucinatory behavior and insula volume in schizophrenia. Results suggest the involvement of social brain areas in both disorders. Further studies are needed to replicate these findings and to quantify the amount of distinct and overlapping neural correlates in autism spectrum disorder and schizophrenia.

Introduction

Autism spectrum disorder (ASD) and schizophrenia (SCZ) are biologically based psychiatric disorders that share a substantial number of etiologic factors and phenotypic characteristics. For instance, rare and partly overlapping copy number variants have been identified to be a strong genetic risk factor for both disorders [1], and relatives of individuals with ASD are more likely to have a family history of SCZ [2].

Both disorders are influenced by deficits of the social brain [2], [3], a specialized neural network dedicated to social cognition comprising in particular the medial prefrontal cortex (MPFC), the posterior temporal sulcus, and the adjacent temporo-parietal junction, the anterior cingulate cortex (ACC), the insula, the amygdala, the inferior frontal gyrus, and the interparietal sulcus [4], [5]. Social cognition refers to psychological processes that benefit social exchanges, in particular, a specific cognitive ability, called “Theory of mind” (ToM) or mentalizing, allows humans to explain and predict the behavior of conspecifics by inferring their mental states [6]. FMRI studies have shown aberrant activation in SCZ and ASD using mentalizing and basic emotional tasks. In SCZ aberrant neural activation in fronto-temporo-parietal regions and in amygdala were found [7][13]. Also, in ASD reduced activation in regions of the social brain during processing of social information has been described in the right pSTS, amygdala and fusiform gyrus [14][21].

Moreover, in both disorders abnormalities in global brain volume measures have been reported when compared to typically developing subjects (TD). In ASD, a greater total brain volume is present mainly in early childhood, rarely in adults [22]. In SCZ, smaller global GM and WM volumes have been reported in meta-analytic studies [23][25]. Meta-analyses of voxel-based morphometry (VBM) studies reported volume alterations of social brain areas in both disorders. In ASD smaller grey matter (GM) volumes were found in the temporal lobe, MPFC, amygdala/hippocampus, and precuneus [26], , instead larger GM volumes have been reported in the lateral prefrontal cortex and temporo-occipital regions [26], [22], [27]. Structural alterations in ASD seem to be age-related, as in adults with ASD structural alterations in fusiform gyrus, cingulum, amygdala and insula were less often reported compared to children/adolescents [22], [27], [1]. Similar to ASD, in SCZ structural alterations have been found in the social brain and meta-analyses have described smaller GM volumes in fronto-temporal regions, ACC, hippocampus/amygdala, and the insula [28][31], [23]. GM alterations were more extensive in patients with long illness duration possibly indicating a neurodegenerative process [29], [30], [32], [28]. A recent meta-analysis implemented anatomical likelihood estimation (ALE) to compare VBM studies on both SCZ and ASD [33]. Lower GM volumes in the limbic-striato-thalamic circuitry compared to controls were found as a structural overlap between SCZ and ASD. Distinct volumetric alterations were observed in the amygdala, caudate, frontal, and medial gyrus (SCZ) and putamen (ASD).

In summary, studies on structural alterations in ASD and SCZ compared to TD have shown GM volume alteration in social brain areas with a high diversity of brain volume changes within the social brain network, which are in part contradictory. The contradictions may be explained by the phenotypic differences within disorders, age and IQ effects, or by different methods used for data acquisition and analysis [32], [31], [27]. Therefore, a direct comparison of both disorders within a unitary methodological framework is necessary to clearly describe overlapping and disorder specific alterations of brain volume [34]. In the present VBM-study, ASD, SCZ, and TD were compared directly with respect to global and regional brain volume. Moreover, structural alterations were correlated with differences in mentalizing abilities and disorder specific symptom severity.

This study aims to address three hypotheses: First, in global brain measures, a slightly lower total GM and total white matter volume is expected in SCZ compared to TD. No differences in global brain measures are expected between ASD and TD, as greater total GM volume was found mainly in ASD children, but not in adults. Second, we hypothesize that in both disorders compared to TD, lower GM volumes are present social brain areas, reflecting impairments in social cognition. As ASD and SCZ show different and in part contrary deficits in social cognition (i.e. in ASD the ability to attribute mental states to others is deficient, while in paranoid SCZ these attributions are intensified), we expect distinct volume alterations comparing SCZ with ASD. Third, associations between the extent of volume alterations in these areas and behavioral data (symptom severity and mentalizing abilities) are expected.

Methods

Participants

Thirty-four patients with ASD (3 females, age range 14 to 33 years, mean age 19.06, SD 5.12; mean IQ 105.73, SD 12.92), 21 patients with SCZ (5 females, aged 14 to 33 years, mean age 24.67, SD 5.20; mean IQ 103.33, SD 11.21), and 26 TD (4 females, aged 14 to 27 years, mean age 19.54, SD 3.46; mean IQ 107.75, SD 11.97) were investigated. The ASD sample consisted of 16 patients with Asperger Syndrome, 11 patients with childhood autism and 7 with atypical autism. The study was approved by the local ethical committee of the medical faculty, JW Goethe-University, Frankfurt am Main, and was carried out according to the declaration of Helsinki. All subjects (and their parents in case of underage subjects) gave their written informed consent for participation in the study.

The following inclusion criteria were met by the clinical groups: 1) diagnoses according to ICD-10 (F84.0, F84.1, F84.5; F20.0); 2) no additional neurological or chronic medical disorder; 3) no other comorbid psychiatric disorder; 4) IQ >70. The diagnosis of paranoid hallucinatory schizophrenia (ICD-10: F20.0) was done by thorough clinical examination and validation by at least 2 experienced psychiatrists. The diagnoses of childhood autism, Asperger Syndrome or atypical autism (ICD-10: F84.0, F84.1, F84.5) was additionally confirmed by the Autism Diagnostic Interview - Revised (ADI-R, German version; [35], [36]) and Autism Diagnostic Observation Schedule (ADOS, German version; [37], [38]). In order to provide additional information on positive and negative symptoms, the Positive and Negative Syndrome Scale (PANSS, [39]) was obtained from SCZ. In SCZ, mean duration of illness was 67 months (SD: 45 months), ranging from 2 months to 144 months. Given the age at examination and the illness duration, 40% to 50% of the patients were considered as adolescent onset schizophrenia and 50% to 60% as adult onset schizophrenia (missing data in 2 datasets).

To exclude additional psychiatric disorders, all subjects were explored by experienced psychiatrists. In addition, participants filled in the youth or young adult self-report (YASR/YSR; [40], [41]), a screening instrument to assess self-rated psychopathology. Also, the child behavior checklist/young adult behavior checklist (CBCL/YABCL; [42], [41]) was completed by a parent, where possible. All TD subjects showed YASR/YSR and CBCL/YABCL subscales T-scores <67 (below borderline clinical cut-off). SCZ were older than ASD and TD. Therefore, age was controlled as a covariate in all further analyses.

Psychological assessment

IQ was measured by the Raven Standard Progressive Matrices (SPM, [43]). Handedness was determined by the Edinburgh handedness inventory [44]. To characterize deficits in mentalizing abilities, all subjects were investigated using the ‘reading the mind in the eyes’ test (RME) [45]. In this test, participants were asked to identify complex emotional and non-affective states in images presenting human eyes.

Demographic data, clinical characteristics, and dosage of daily neuroleptic treatment chlorpromazine equivalent doses according to Woods [46] are shown in Table 1. Within the SCZ sample, 21 patients were treated with at least one of the following substances: Risperidone/Paliperidone (7), Quetiapine (5), Olanzapine (2), Clozapine (4), Aripiprazole (2), Haloperidol (1), Benperidol (2), Chlorprothixen (2); Escitalopram (1), Fluvoxamine (1), Ziprasidone (1); (missing data in 2 datasets); within the ASD sample 7 patients were treated with at least one of the following substances: Risperidone (2); Methylphenidate (5); Sertraline (2), Escitalopram (1).

thumbnail
Table 1. Sociodemographical and clinical parameters of ASD, SCZ and TD.

https://doi.org/10.1371/journal.pone.0106539.t001

Data acquisition and voxel-based-morphometry analysis

Structural magnetic resonance images were acquired using a 3 Tesla Siemens Allegra scanner (Erlangen, Germany) with a 1-channel head coil. Data were recorded using a T1-weighted MDEFT-sequence [47] with parameters as follows: TR: 10.55 ms, TE: 3.06 ms; TI: 680 ms; flip angle: 22°. One dataset consisted of 176 axial images with an inplane resolution of 1 mm3, field of view: 256 mm; slice thickness: 1 mm.

Imaging data pre-processing

All datasets were manually reviewed for head motion and image quality. Datasets with low image quality or motion artefacts were excluded from analysis. Structural images underwent pre-processing using optimized VBM as implemented in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8) according to the standardized procedure [48]. Images were segmented into GM and white matter (WM). Global GM, global WM, and total brain volume (TBV) were calculated. Subsequently, images were normalized by creating a DARTEL-template to provide an increased accuracy of inter-subject alignment. The images were resampled to 1.5×1.5×1.5 mm3 voxel size. Images were smoothed (using an 8 mm FWHM isotropic Gaussian kernel) and normalized to MNI space. Data were corrected for differences in global GM/WM volume. As treatment with neuroleptic medication differed between groups, daily chlorpromazine-equivalents were tested for association with local volume alterations in SCZ.

Statistical analysis

Total tissue volumes were calculated by summing the partial volume estimates multiplied by the voxel volume across the entire brain. Between-group differences in global brain measures were examined using an ANOVA with factor group including age as a covariate. Subsequent comparisons between means were performed using Bonferroni’s post hoc test. Individual GM and WM segments were subjected to a voxel-wise multiple regression analysis. The differential effects of the three groups (ASD, SCZ and TD) were assessed within an ANCOVA model including age and global GM or global WM volume as covariates. ANCOVA was followed by between group comparisons. Significance threshold was set at P<0.001, uncorrected (K>20). Anatomical regions and denominations are reported according to the atlas of Talairach [49], [50]. Coordinates are provided as maxima in given clusters according to the standard MNI-template. To identify brain abnormalities in ASD und SCZ associated with illness severity and social cognition, individual peak voxel data were extracted from the regions resulting from between groups comparison and associated with RME, ADOS, and PANSS using Pearson’s correlation. Results reported as significant were defined as P<0.05 and r>0.4. Data were analysed using SPSS Statistics version 17.0.

Results

Global brain measures

Global brain measures were calculated in ASD (global GM [mean, SD]: 790.26 ml, 52.32 ml; global WM: 535.93 ml, 41.28 ml; TBV: 1326.19 ml, 94.87 ml), SCZ (global GM [mean, SD]: 731.69 ml, 85.63 ml; global WM: 518.96 ml, 59.08 ml; TBV: 1250.65 ml, 142.79 ml), and TD (global GM [mean, SD]: 777.48 ml, 52.31 ml; global WM: 537.50 ml, 42.53 ml; TBV: 1314.98 ml, 92.43 ml). No differences were found between groups in global GM (F2,77 = 2.365; P = 0.101), WM (F2,77 = 0.894; P = 0.413) or TBV (F2,77 = 1.640; P = 0.201) (Figure 1).

thumbnail
Figure 1. Box plots of global brain measures.

Box plots are given for autism spectrum disorder (ASD), schizophrenia (SCZ) and typically developed control subjects (TD) each with global gray matter (GM), global white matter (WM) and total brain volume (TBV). The horizontal line in each box indicates the median, while the top and bottom borders of the box mark the 25th and 75th percentile, respectively. The vertical lines above and below the box mark the range of distribution.

https://doi.org/10.1371/journal.pone.0106539.g001

Voxel based morphometry

As results did not survive a FWE/FDR correction, they are given on a P<0.001 level, uncorrected. A main effect of group was observed for GM volume in the left anterior insula (AI), left amygdala and occipital medial area (Table 2). No main effect of group was found for WM volume. Thus, between groups analysis was performed for GM only. In the contrast SCZ vs. ASD, GM volume in left AI was smaller in ASD (Figure 2). In the contrast ASD vs. TD, smaller GM volumes were found in ASD in left amygdala, left AI and additionally in the anterior MPFC and right amygdala (Figure 2). In the medial occipital area, GM volume was larger in ASD. The contrast SCZ vs. TD did not reveal any significant GM alterations.

thumbnail
Figure 2. Results of conjunctional VBM analysis of T contrasts.

All statistical parametric maps were thresholded at P<0.001 with a cluster level K>20, age was added as a covariate. In column diagrams, beta-values are given for each cluster. Significant contrasts (P<0.05) are marked with star (*). Left: contrast TD>ASD in a coronal view (Y = −5); Middle: contrast TD>ASD in a saggital view (X = −2); Right: contrast SCZ>ASD in a coronal view (Y = 14).

https://doi.org/10.1371/journal.pone.0106539.g002

thumbnail
Table 2. Summary of main effect results and between group analyses in MNI space on a p<0.001 level.

https://doi.org/10.1371/journal.pone.0106539.t002

Antipsychotic treatment must be considered as a potential bias on regional brain volume. No association was observed with amygdala, insula, or MPFC volume and chlorpromazine-equivalents.

Correlations between volumetric and behavioral data

In SCZ, a positive correlation was found between left AI GM volume and the PANSS hallucinatory behavior score (r = 0.56; P = 0.008). No correlation was found between GM alterations and illness duration. In ASD, a positive correlation was found between left amygdala volume and the RME-score (r = 0.41; P = 0.015) (Figure 3). As one peripheral data point (Figure 3, data point (0.37/7)) was suspect being an outlier, a second analysis was performed with the remaining data. The correlation persisted on a trend level.

thumbnail
Figure 3. Correlation plots.

Left: Correlation between left amygdala GM volume (beta-values) and the ‘reading the mind in the eyes’-score (RME) in autism spectrum disorder (r = 0.41; P = 0.015). The RME-score represents the number of correctly identified emotions of pictures depicting facial expressions (maximum score = 28). Right: Correlation between left insular GM volume (beta-values) and the PANSS hallucinatory behaviour score in schizophrenia (r = 0.56; P = 0.008). The hallucinatory behaviour score represents the degree of a patient’s verbal report or behaviour indicating perceptions which are not generated by external stimuli. The score ranges between 1 (absent) and 7 (extreme).

https://doi.org/10.1371/journal.pone.0106539.g003

Discussion

To our knowledge, this is the first structural MRI study that compared ASD and SCZ directly. The following main findings were revealed: 1) No global GM or WM alterations were present between groups. 2) In VBM analysis, GM alterations were present mainly in regions associated with social cognition (amygdala, MPFC and insula). Direct comparison of both disorders demonstrated a smaller GM volume in the left anterior Insula (AI) in ASD compared to SCZ. ASD showed smaller local GM volumes compared to TD in the bilateral amygdala, left AI and anterior MPFC. No differences were found between SCZ and TD. 3) Alterations in GM volume correlated significantly with specific parameters of psychopathology and social abilities: hallucinatory behavior with AI volume in SCZ, and mentalizing abilities with amygdala volume in ASD.

Global brain measures

No alterations in global GM/WM were found between groups. Although meta-analytic studies in SCZ reported alterations in global brain parameters such as smaller global GM, global WM and TBV [23], [51], [52] original data reported contradicting results. Out of 32 cross-sectional studies, that were included in meta-analytic studies on first episode SCZ [24], [53], only 7 studies reported significant results. As alterations are subtle [54], large samples are needed to detect these differences. Thus, it is not surprising, that in our study, no differences between groups regarding global brain measures were detected. In ASD compared to TD, previous studies reported larger GM, WM and TBV predominantly in children, but not in the adult population [22]. This is in accordance with results of this study.

Voxel based morphometry

1. Direct comparison of ASD and SCZ.

This study suggests a dysfunctional involvement of the AI in both disorders. ASD patients showed a smaller GM volume in the left AI compared to SCZ, whereas a positive correlation was found between insular GM volume in SCZ and PANSS hallucinatory behavior score.

In ASD and SCZ, the insula was consistently affected in structural and functional MRI studies [30], [55][57], [29], [58], [28]. Similar, smaller insular GM volumes were found in SCZ and ASD in a study using an anatomical likelihood estimation (ALE) approach [33].

The AI is an extensively connected, multifaceted brain region that is involved in numerous brain functions [59]. This brain region is highly involved in processing sensory stimuli with a unique role in interoception, monitoring the physiological reaction like heartbeat frequency, skin conductance, pain and touch [60][63] and also the emotional component of interoceptive awareness [64], [65]. The interceptive awareness of the body as an independent entity that is distinct from external environment, is a precondition for self and non-self discrimination [66], [59]. Furthermore, AI has been implicated in empathic abilities [67], [68], [62] and is involved in auditory and facial affect processing [69][71]. One theory, the salience network hypothesis [72][74] conceptualizes the disparate AI functions using a comprehensive “network perspective”. According to this model, the AI is the integral hub of the salience network, and represents a multimodal salience detector that identifies the most relevant among several internal and external stimuli. It is associated with segregate functions (i.e. processing of sensory information like pain, social cues like facial expressions, and the analysis of own emotional state) which all facilitate subjectively relevant information.

A salience network dysfunction has been proposed to play a major role in ASD and SCZ [72], [75][78]. In ASD the smaller insular GM volume found in this study fits well with AI hypo-activity reported by fMRI studies on tasks of social cognition [58]. A structural insular abnormality might lead to a disconnection between the AI and sensory and limbic structures, resulting in limited ability to identify salient stimuli necessary for adapting adequately to the social environment [72]. Due to this dysfunction, social cues might not be identified as salient and thus not labelled as emotionally rewarding in the insula. In contrast, sensory stimuli might be considered as salient, which may underlie sensory interests, repetitive behavior, or even anxiety and avoidance in ASD.

In SCZ, brain regions underlying the salience network are consistently changed, in example the insular cortex [79], [29], [80], [77]. Studies on high-risk individuals show, that smaller GM volume of ACC and Insula, both major regions of the salience network, are associated with transition to psychosis [81], [82]. Salience network dysfunction has been proposed to play a key role in positive and negative symptoms in SCZ [75], [83], [77]. In this study, we found a significant relation between insula volume and PANSS hallucinatory behavior score. Hallucinations can be conceptionalized as a failure to differentiate an internally generated from an externally sensory experience [84], [85]. Functional and structural studies revealed that the insula, along with regions traditionally known as language areas, seem to play a key role in auditory hallucinations in SCZ [86][92]: A Insula dysfunction might cause a confusion of the two sources, resulting in internal sensory information being attributed to external sources [93]. Audible thoughts, thought insertions, and hallucinations might be the consequence. Still, a positive correlation between insula volume and PANSS hallucinatory behaviour score was surprising as it stays in contrast to reports of insular GM volume loss in SCZ [29]. Further studies are needed to investigate significance of these alterations in more detail and to resolve the mentioned inconsistencies.

2. Direct comparison of ASD and TD.

The ASD group was characterized by significantly smaller GM volumes in bilateral amygdala, left AI and anterior MPFC compared to TD. Hence, only areas involved in social cognition were significantly smaller. Smaller GM volume in the amygdala-hippocampal complex represents a common finding in VBM-studies in ASD [53], [94][97]. The amygdala is involved in emotion recognition and affective Theory of Mind and is thus a key player in social cognition [98]. The association of social impairment and abnormalities of the amygdala have been reported across many different scientific fields [99][101]. In a meta-analysis of functional neuroimaging studies in ASD, hypoactivation of the amygdala has been found in different social cognitive tasks [102], [103]. Because a smaller cortical GM volume has been frequently associated with a reduced function in the affected structure [104], the smaller GM volume in the amygdala in ASD fits well to the lower amygdala activation in functional neuroimaging studies. This is supported by the positive correlation we found between mentalizing abilities and amygdala volume in ASD.

In agreement with results of this study, Mc Alonan found a significantly smaller insular GM volume in ASD [105]. Greater insular surface area is associated with poorer social behaviour in ASD [106] and a meta-analysis of functional MRI studies examining social processing identified the AI as a consistent locus of hypo-activity in autism [58]. Altered functional connectivity of AI with Amygdala and somatosensory regions were also present in ASD [107]. These structural and functional findings could underlie typical ASD symptoms like altered emotional experiences and impaired social abilities.

In MPFC, we found a smaller GM volume in ASD. According to a functional division of the MPFC this area is located in the anterior MPFC [108]. The MPFC, in particular its anterior part, is a key region of mentalizing abilities. It is involved during communicative intention [109][112] and triadic interactions [113]{Amodio 2006 #141 [114], [115]. Different lines of evidence imply alterations of MPFC in ASD. For example, injuries of the MPFC have led to deficient mentalizing abilities and autism-like behavior [116]; histologic abnormalities in this region have been found in animal models of autism [117], [118], and in postmortem-studies of ASD patients [119]. Different neuroimaging techniques have revealed a reduced activity in the MPFC in ASD patients using MEG [120], PET [121], and functional MRI during Theory of Mind tasks [122], [14]. The reduced activity in the MPFC corresponds well with the smaller GM volume across ages described in previous meta-analyses [27]. This study provides an additional confirmation for this finding.

3. Direct comparison of SCZ and TD.

No structural alterations were found in SCZ compared to TD. This is in disagreement with our hypothesis, as brain volume alterations were expected in areas encoding social cognition in SCZ. Smaller regional brain volumes were consistently reported in meta-analyses [55], [31], [29]. However, these results are highly heterogeneous, as age of onset and illness duration influence results of VBM analyses causing different alterations in regional GM volume [28], [31]. In this study, three aspects might explain the lack of observed differences between SCZ and TD: First, SCZ comprised the smallest group of participants. Thus, the study has lacked power to find smaller volumetric changes [123], which must be considered as a limitation. Second, with a mean age of 24.7 years (range 14 to 33 years) the SCZ patients in our study were relatively young. In SCZ, GM alterations are more pronounced in samples with rising illness duration and age [51]. Third, the examined population was a mixed sample of adolescent-onset SCZ and adult-onset SCZ. A heterogeneous sample in terms of age of onset might have contributed to a lack of alterations in GM volume in this contrast.

Study limitations

Some aspects must be considered as limitations of this study. (1) The study was designed to detect only large volume differences; due to limited sample size and a lack of power, possibly existing smaller volume alterations were not detected. We can therefore only interpret the differences detected in our study but not the lack of differences. Results need to be considered preliminary, as they were reported given on a p<0.001 level and did not withstand a more stringent and conservative correction for multiple comparisons across the brain. (2) The SCZ sample was heterogeneous in regards of disease onset comprising both adolescent and adult onset schizophrenia.

Conclusion

In summary, this study compared ASD and SCZ patients directly for global and regional alterations in brain structure. Results emphasize distinct brain substrate in both disorders, as GM alterations of the social brain were prominent in ASD only. Still, we found that disturbances in the insula may play an important role in both conditions. As a morphologic correlate, this study revealed a lower insular GM volume in ASD; in SCZ individuals, a positive correlation of insular GM volume and PANSS hallucinatory behavior score was found, which contrasts to smaller insular volume frequently reported in SCZ. Further studies are needed to replicate the described findings and investigate neurophysiological significance of these alterations for ASD and SCZ in more detail.

Author Contributions

Conceived and designed the experiments: AC MS DH SS BW SB FP HW. Performed the experiments: AC DH SS BW SB FP HW. Analyzed the data: DR AC MS HW CMF. Contributed reagents/materials/analysis tools: DR AC MS DH SS SB FP HW CMF. Contributed to the writing of the manuscript: DR AC MS DH SS BW SB FP HW CMF.

References

  1. 1. Guilmatre A, Dubourg C, Mosca A, Legallic S, Goldenberg A, et al. (2009) Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66 (9): 947–956.
  2. 2. Pelphrey KA, Shultz S, Hudac CM, Vander Wyk BC (2011) Research Review: Constraining heterogeneity: the social brain and its development in autism spectrum disorder. J Child Psychol Psychiatry 52 (6): 631–644.
  3. 3. Burns J (2006) The social brain hypothesis of schizophrenia. World Psychiatry 5 (2): 77–81.
  4. 4. Adolphs R (2003) Cognitive neuroscience of human social behaviour. Nat Rev Neurosci 4 (3): 165–178.
  5. 5. Frith CD, Frith U (2007) Social Cognition in Humans. Curr Biol 17 (16): R724–32.
  6. 6. Frith CD, Frith U (2006) How we predict what other people are going to do. Brain Res 1079 (1): 36–46.
  7. 7. Brunet E, Sarfati Y, Hardy-Baylé M, Decety J (2003) Abnormalities of brain function during a nonverbal theory of mind task in schizophrenia. Neuropsychologia 41 (12): 1574–1582.
  8. 8. Brüne M, Abdel-Hamid M, Sonntag C, Lehmkämper C, Langdon R (2009) Linking social cognition with social interaction: Non-verbal expressivity, social competence and “mentalising” in patients with schizophrenia spectrum disorders. Behav Brain Funct 5 (1): 6.
  9. 9. Das P, Lagopoulos J, Coulston CM, Henderson AF, Malhi GS (2012) Mentalizing impairment in schizophrenia: A functional MRI study. Schizophr Res 134 (2–3): 158–164.
  10. 10. Pedersen A, Koelkebeck K, Brandt M, Wee M, Kueppers KA, et al. (2012) Theory of mind in patients with schizophrenia: Is mentalizing delayed. Schizophr Res 137 (1–3): 224–229.
  11. 11. Walter H, Ciaramidaro A, Adenzato M, Vasic N, Ardito RB, Erk S, Bara BG (2009) Dysfunction of the social brain in schizophrenia is modulated by intention type: An fMRI study. Soc Cogn Affect Neurosci 4(2): 166–76.
  12. 12. Pinkham AE, Hopfinger JB, Pelphrey KA, Piven J, Penn DL (2008) Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophr Res 99 (1–3): 164–175.
  13. 13. Johnston PJ, Stojanov W, Devir H, Schall U (2005) Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates. Eur J Neurosci 22 (5): 1221–1232.
  14. 14. Castelli F (2002) Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain 125 (8): 1839–1849.
  15. 15. Kana RK, Libero LE, Hu CP, Deshpande HD, Colburn JS (2012) Functional Brain Networks and White Matter Underlying Theory-of-Mind in Autism. Soc Cogn Affect Neurosci 9(1): 98–105.
  16. 16. Lombardo MV, Chakrabarti B, Bullmore ET, Baron-Cohen S (2011) Specialization of right temporo-parietal junction for mentalizing and its relation to social impairments in autism. Neuroimage 56 (3): 1832–1838.
  17. 17. Critchley HD, Daly EM, Bullmore ET, Williams SC, van Amelsvoort T, et al. (2000) The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 123 (Pt 11): 2203–2212.
  18. 18. Wang AT, Dapretto M, Hariri AR, Sigman M, Bookheimer SY (2004) Neural correlates of facial affect processing in children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 43 (4): 481–490.
  19. 19. Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Tsujii M, et al. (2011) Reduced acetylcholinesterase activity in the fusiform gyrus in adults with autism spectrum disorders. Arch Gen Psychiatry 68 (3): 306–313.
  20. 20. Kleinhans NM, Richards T, Johnson LC, Weaver KE, Greenson J, et al. (2011) fMRI evidence of neural abnormalities in the subcortical face processing system in ASD. Neuroimage 54 (1): 697–704.
  21. 21. Pelphrey KA, Morris JP, McCarthy G (2005) Neural basis of eye gaze processing deficits in autism. Brain 128 (Pt 5): 1038–1048.
  22. 22. Stanfield AC, McIntosh AM, Spencer MD, Philip R, Gaur S, et al. (2008) Towards a neuroanatomy of autism: A systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur Psychiatry 23 (4): 289–299.
  23. 23. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, et al. (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157 (1): 16–25.
  24. 24. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188: 510–518.
  25. 25. Vita A, Peri L de, Silenzi C, Dieci M (2006) Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82 (1): 75–88.
  26. 26. Nickl-Jockschat T, Habel U, Maria Michel T, Manning J, Laird AR, et al. (2011) Brain structure anomalies in autism spectrum disorder-a meta-analysis of VBM studies using anatomic likelihood estimation. Hum Brain Mapp 33(6): 1470–89.
  27. 27. Duerden EG, Mak-Fan KM, Taylor MJ, Roberts SW (2012) Regional differences in grey and white matter in children and adults with autism spectrum disorders: an activation likelihood estimate (ALE) meta-analysis. Autism Res 5 (1): 49–66.
  28. 28. Chan RCK, Di X, McAlonan GM, Gong Q (2010) Brain Anatomical Abnormalities in High-Risk Individuals, First-Episode, and Chronic Schizophrenia: An Activation Likelihood Estimation Meta-analysis of Illness Progression. Schizophr Bull 37 (1): 177–188.
  29. 29. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E (2008) The Anatomy of First-Episode and Chronic Schizophrenia: An Anatomical Likelihood Estimation Meta-Analysis. Am J Psychiatry 165 (8): 1015–1023.
  30. 30. Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36(4): 1342–56.
  31. 31. Honea R, Crow TJ, Passingham D, Mackay CE (2005) Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162 (12): 2233–2245.
  32. 32. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, et al. (2011) Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry 70 (1): 88–96.
  33. 33. Cheung C, Yu K, Fung G, Leung M, Wong C, et al. (2010) Autistic Disorders and Schizophrenia: Related or Remote? An Anatomical Likelihood Estimation. PLoS ONE 5 (8): e12233.
  34. 34. Sasson NJ, Pinkham AE, Carpenter KLH, Belger A (2011) The benefit of directly comparing autism and schizophrenia for revealing mechanisms of social cognitive impairment. J Neurodevelop Disord 3 (2): 87–100.
  35. 35. Le Rutter M, Couteur A., Lord C. (2003) Autism Diagnostic Interview - Revised (ADI-R). Los Angeles, CA: Western Psychological Services.
  36. 36. Bölte S, Rühl D., Schmötzer G., Poustka F. (2006) Diagnostisches Interview für Autismus – revidiert. Bern: Huber.
  37. 37. Lord C, Rutter M., DiLavore P., Risi S. (2001) Autism Diagnostic Schedule (ADOS). Los Angeles, CA: Western Psychological Services.
  38. 38. Rühl D, Bölte S., Feineis-Matthews S., Poustka F. (2004) Diagnostische Beobachtungsskala für Autistische Störungen (ADOS). Bern: Huber.
  39. 39. Kay SR, Opler LA, Lindenmayer JP (1989) The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl (7): 59–67.
  40. 40. Achenbach T (1991) Manual for the Youth Self-Report and 1991 profile.: University of Vermont, Departement of Psychiatry.
  41. 41. Achenbach T (1997) Manual for the Young Adult Self-Report and Young Adult Behavior Checklist.: University of Vermont, Departement of Psychiatry.
  42. 42. Achenbach T (1991) Manual for the Child Behavior Checklist and 1991 profile.: University of Vermont, Departement of Psychiatry.
  43. 43. Kratzmeier H, Horn R (1988) Standard Progressive Matrices. Weinheim: Beltz.
  44. 44. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 (1): 97–113.
  45. 45. Baron-Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I (2001) The “Reading the Mind in the Eyes” Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry 42 (2): 241–251.
  46. 46. Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64 (6): 663–667.
  47. 47. Deichmann R, Schwarzbauer C, Turner R (2004) Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. Neuroimage 21. (2): 757–767.
  48. 48. Ashburner J (2010) VBM Tutorial. Available: http://www.fil.ion.ucl.ac.uk/~john/misc/VBMclass10.pdf.
  49. 49. Talairach J TP (1988) Co-Planar Stereotactic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging. New York: Thieme Medical Publishers.
  50. 50. Duvernoy HM (1991) The Human Brain: Surface, Three-Dimensional Sectional Anatomy and MRI. New York: Springer.
  51. 51. Hulshoff Pol HE, Kahn RS (2008) What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr Bull 34 (2): 354–366.
  52. 52. Shenton ME, Dickey CC, Frumin M, McCarley RW (2001) A review of MRI findings in schizophrenia. Schizophr Res 49 (1–2): 1–52.
  53. 53. Via E, Radua J, Cardoner N, Happé F, Mataix-Cols D (2011) Meta-analysis of gray matter abnormalities in autism spectrum disorder: should Asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder. Arch Gen Psychiatry 68 (4): 409–418.
  54. 54. Harrison PJ, Freemantle N, Geddes JR (2003) Meta-analysis of brain weight in schizophrenia. Schizophr Res 64 (1): 25–34.
  55. 55. Bora E, Fornito A, Radua J, Walterfang M, Seal M, et al. (2011) Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res 127 (1–3): 46–57.
  56. 56. Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, et al. (2008) Meta-Analysis of Gray Matter Anomalies in Schizophrenia: Application of Anatomic Likelihood Estimation and Network Analysis. Biol Psychiatry 64 (9): 774–781.
  57. 57. Fornito A, Yücel M, Patti J, Wood S, Pantelis C (2009) Mapping grey matter reductions in schizophrenia: An anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 108 (1–3): 104–113.
  58. 58. Di Martino A, Ross K, Uddin LQ, Sklar AB, Castellanos FX, et al. (2009) Functional Brain Correlates of Social and Nonsocial Processes in Autism Spectrum Disorders: An Activation Likelihood Estimation Meta-Analysis. Biological Psychiatry 65 (1): 63–74.
  59. 59. Craig ADB (2009) How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci 10 (1): 59–70.
  60. 60. Ochsner KN, Zaki J, Hanelin J, Ludlow DH, Knierim K, et al. (2008) Your pain or mine? Common and distinct neural systems supporting the perception of pain in self and other. Soc Cogn Affect Neurosci 3 (2): 144–160.
  61. 61. Critchley HD, Wiens S, Rotshtein P, Öhman A, Dolan RJ (2004) Neural systems supporting interoceptive awareness. Nat Neurosci 7 (2): 189–195.
  62. 62. Singer T, Seymour B, O’Doherty J, Kaube H, Dolan RJ, et al. (2004) Empathy for pain involves the affective but not sensory components of pain. Science 303 (5661): 1157–1162.
  63. 63. Lovero KL, Simmons AN, Aron JL, Paulus MP (2009) Anterior insular cortex anticipates impending stimulus significance. Neuroimage 45 (3): 976–983.
  64. 64. Craig ADB (2003) Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 13 (4): 500–505.
  65. 65. Critchley HD (2002) Volitional Control of Autonomic Arousal: A Functional Magnetic Resonance Study. Neuroimage 16 (4): 909–919.
  66. 66. Devue C, Collette F, Balteau E, Degueldre C, Luxen A, et al. (2007) Here I am: The cortical correlates of visual self-recognition. Brain Res 1143: 169–182.
  67. 67. Jabbi M, Swart M, Keysers C (2007) Empathy for positive and negative emotions in the gustatory cortex. Neuroimage 34 (4): 1744–1753.
  68. 68. Saarela MV, Hlushchuk Y, Williams ACC de, Schürmann M, Kalso E, et al. (2007) The compassionate brain: humans detect intensity of pain from another’s face. Cereb Cortex 17 (1): 230–237.
  69. 69. Wicker B, Keysers C, Plailly J, Royet JP, Gallese V, et al. (2003) Both of us disgusted in My insula: the common neural basis of seeing and feeling disgust. Neuron 40 (3): 655–664.
  70. 70. Carr L, Iacoboni M, Dubeau M, Mazziotta JC, Lenzi GL (2003) Neural mechanisms of empathy in humans: a relay from neural systems for imitation to limbic areas. Proc Natl Acad Sci U S A 100 (9): 5497–5502.
  71. 71. Quadflieg S, Mohr A, Mentzel H, Miltner WHR, Straube T (2008) Modulation of the neural network involved in the processing of anger prosody: the role of task-relevance and social phobia. Biol Psychol 78 (2): 129–137.
  72. 72. Uddin LQ, Menon V (2009) The anterior insula in autism: Under-connected and under-examined. Neurosci Biobehav Rev 33 (8): 1198–1203.
  73. 73. Menon V, Uddin LQ (2010) Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 214 (5–6): 655–667.
  74. 74. Toyomaki A, Murohashi H (2013) “Salience network” dysfunction hypothesis in autism spectrum disorders. Jpn Psychol Res 55 (2): 175–185.
  75. 75. Manoliu A, Riedl V, Zherdin A, Muhlau M, Schwerthoffer D, et al. (2013) Aberrant Dependence of Default Mode/Central Executive Network Interactions on Anterior Insular Salience Network Activity in Schizophrenia. Schizophr Bull 40(2): 428–37.
  76. 76. Manoliu A, Riedl V, Doll A, Bäuml JG, Mühlau M, et al. (2013) Insular Dysfunction Reflects Altered Between-Network Connectivity and Severity of Negative Symptoms in Schizophrenia during Psychotic Remission. Front Hum Neurosci 7: 216.
  77. 77. Palaniyappan L (2012) Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. J Psychiatry Neurosci 37 (1): 17–27.
  78. 78. Lee S, Chun JW, Lee JS, Park H, Jung Y, et al. (2014) Abnormal Neural Processing during Emotional Salience Attribution of Affective Asymmetry in Patients with Schizophrenia. PLoS ONE 9 (3): e90792.
  79. 79. Shepherd AM, Matheson SL, Laurens KR, Carr VJ, Green MJ (2012) Systematic Meta-Analysis of Insula Volume in Schizophrenia. Biological Psychiatry 72 (9): 775–784.
  80. 80. Ellison-Wright I, Bullmore E (2009) Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res 108 (1–3): 3–10.
  81. 81. Borgwardt SJ, Riecher-Rössler A, Dazzan P, Chitnis X, Aston J, et al. (2007) Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 61 (10): 1148–1156.
  82. 82. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, et al. (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361 (9354): 281–288.
  83. 83. Palaniyappan L, Simmonite M, White TP, Liddle EB, Liddle PF (2013) Neural Primacy of the Salience Processing System in Schizophrenia. Neuron 79 (4): 814–828.
  84. 84. Frith CD, Done DJ (1988) Towards a neuropsychology of schizophrenia. Br J Psychiatry 153: 437–443.
  85. 85. Ford JM, Mathalon DH (2004) Electrophysiological evidence of corollary discharge dysfunction in schizophrenia during talking and thinking. J Psychiatr Res 38 (1): 37–46.
  86. 86. Palaniyappan L, Balain V, Radua J, Liddle PF (2012) Structural correlates of auditory hallucinations in schizophrenia: A meta-analysis. Schizophr Res 137 (1–3): 169–173.
  87. 87. Copolov DL, Seal ML, Maruff P, Ulusoy R, Wong MT, et al. (2003) Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res: Neuroimage 122 (3): 139–152.
  88. 88. Diederen KMJ, Neggers SFW, Daalman K, Blom JD, Goekoop R, et al. (2010) Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. Am J Psychiatry 167 (4): 427–435.
  89. 89. Hoffman RE, Anderson AW, Varanko M, Gore JC, Hampson M (2008) Time course of regional brain activation associated with onset of auditory/verbal hallucinations. Br J Psychiatry 193 (5): 424–425.
  90. 90. Jardri R, Pouchet A, Pins D, Thomas P (2011) Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. Am J Psychiatry 168 (1): 73–81.
  91. 91. Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK (2000) Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 57 (11): 1033–1038.
  92. 92. Shergill SS, Brammer MJ, Amaro E, Williams SCR, Murray RM, et al. (2004) Temporal course of auditory hallucinations. Br J Psychiatry 185: 516–517.
  93. 93. Wylie KP, Tregellas JR (2010) The role of the insula in schizophrenia. Schizophr Res 123 (2–3): 93–104.
  94. 94. Brieber S, Neufang S, Bruning N, Kamp-Becker I, Remschmidt H, et al. (2007) Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. J Child Psychol Psychiatry 48 (12): 1251–1258.
  95. 95. Dziobek I, Fleck S, Rogers K, Wolf OT, Convit A (2006) The ‘amygdala theory of autism’ revisited: Linking structure to behavior. Neuropsychologia 44 (10): 1891–1899.
  96. 96. Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, et al. (1999) MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 53 (9): 2145–2150.
  97. 97. Pierce K, Müller RA, Ambrose J, Allen G, Courchesne E (2001) Face processing occurs outside the fusiform ‘face area’ in autism: evidence from functional MRI. Brain 124 (Pt 10): 2059–2073.
  98. 98. Siegal M, Varley R (2002) Neural systems involved in “theory of mind”. Nat Rev Neurosci 3 (6): 463–471.
  99. 99. Bauman ML, Kemper TL (2005) Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci 23 (2–3): 183–187.
  100. 100. Baron-Cohen S, Ring HA, Bullmore ET, Wheelwright S, Ashwin C, et al. (2000) The amygdala theory of autism. Neurosci Biobehav Rev 24 (3): 355–364.
  101. 101. Machado CJ, Bachevalier J (2006) The impact of selective amygdala, orbital frontal cortex, or hippocampal formation lesions on established social relationships in rhesus monkeys (Macaca mulatta). Behav Neurosci 120 (4): 761–786.
  102. 102. Sugranyes G, Kyriakopoulos M, Corrigall R, Taylor E, Frangou S, et al. (2011) Autism Spectrum Disorders and Schizophrenia: Meta-Analysis of the Neural Correlates of Social Cognition. PLoS ONE 6 (10): e25322.
  103. 103. Dickstein DP, Pescosolido MF, Reidy BL, Galvan T, Kim KL, et al. (2013) Developmental meta-analysis of the functional neural correlates of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 52 (3): 279–289.e16.
  104. 104. May A, Gaser C (2006) Magnetic resonance-based morphometry: a window into structural plasticity of the brain. Curr Opin Neurol 19 (4): 407–411.
  105. 105. McAlonan GM, Suckling J, Wong N, Cheung V, Lienenkaemper N, et al. (2008) Distinct patterns of grey matter abnormality in high-functioning autism and Asperger’s syndrome. J Child Psychol Psychiatry 49 (12): 1287–1295.
  106. 106. Doyle-Thomas KAR, Kushki A, Duerden EG, Taylor MJ, Lerch JP, et al. (2013) The Effect of Diagnosis, Age, and Symptom Severity on Cortical Surface Area in the Cingulate Cortex and Insula in Autism Spectrum Disorders. J Child Neurol 28 (6): 732–739.
  107. 107. Ebisch SJ, Gallese V, Willems RM, Mantini D, Groen WB, et al. (2011) Altered intrinsic functional connectivity of anterior and posterior insula regions in high-functioning participants with autism spectrum disorder. Hum Brain Mapp 32 (7): 1013–1028.
  108. 108. Amodio DM, Frith CD (2006) Meeting of minds: the medial frontal cortex and social cognition. Nat Rev Neurosci 7 (4): 268–277.
  109. 109. Walter H, Adenzato M, Ciaramidaro A, Enrici I, Pia L, et al. (2004) Understanding intentions in social interaction: the role of the anterior paracingulate cortex. J Cogn Neurosci 16 (10): 1854–1863.
  110. 110. Kampe KKW, Frith CD, Frith U (2003) “Hey John”: signals conveying communicative intention toward the self activate brain regions associated with “mentalizing,” regardless of modality. J. Neurosci 23 (12): 5258–5263.
  111. 111. Gallagher HL, Jack AI, Roepstorff A, Frith CD (2002) Imaging the Intentional Stance in a Competitive Game. Neuroimage 16 (3): 814–821.
  112. 112. Ciaramidaro A, Becchio C, Colle L, Bara BG, Walter H (2013) Do you mean me? Communicative intentions recruit the mirror and the mentalizing system. Social Cognitive and Affective Neuroscience [Epub ahead of print].
  113. 113. Schilbach L, Wilms M, Eickhoff SB, Romanzetti S, Tepest R, et al. (2010) Minds made for sharing: initiating joint attention recruits reward-related neurocircuitry. J Cogn Neurosci 22 (12): 2702–2715.
  114. 114. Frith U, Frith CD (2003) Development and neurophysiology of mentalizing. Philos Trans R Soc Lond B Biol Sci 358 (1431): 459–473.
  115. 115. Saxe R (2006) Uniquely human social cognition. Curr Opin Neurobiol 16 (2): 235–239.
  116. 116. Umeda S, Mimura M, Kato M (2010) Acquired personality traits of autism following damage to the medial prefrontal cortex. Soc Neurosci 5 (1): 19–29.
  117. 117. Rinaldi TR (2008) Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front Neural Circuits 2: 4.
  118. 118. Testa-Silva G, Loebel A, Giugliano M, Kock CPJ de, Mansvelder HD, et al. (2012) Hyperconnectivity and Slow Synapses during Early Development of Medial Prefrontal Cortex in a Mouse Model for Mental Retardation and Autism. Cereb Cortex 22 (6): 1333–1342.
  119. 119. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, et al. (2011) Neuron number and size in prefrontal cortex of children with autism. JAMA 306 (18): 2001–2010.
  120. 120. Honaga E, Ishii R, Kurimoto R, Canuet L, Ikezawa K, et al. (2010) Post-movement beta rebound abnormality as indicator of mirror neuron system dysfunction in autistic spectrum disorder: An MEG study. Neurosci Lett 478 (3): 141–145.
  121. 121. Nieminen-von Wendt T, Metsähonkala L, Kulomäki T, Alto S, Autti T, et al. (2003) Changes in cerebral blood flow in Asperger syndrome during theory of mind tasks presented by the auditory route. Eur Child Adolesc Psychiatry 12 (4): 178–189.
  122. 122. Wang AT, Lee SS, Sigman M, Dapretto M (2007) Reading affect in the face and voice: neural correlates of interpreting communicative intent in children and adolescents with autism spectrum disorders. Arch Gen Psychiatry 64 (6): 698–708.
  123. 123. Steen R, Hamer R, Lieberman J (2007) Measuring Brain Volume by MR Imaging: Impact of Measurement Precision and Natural Variation on Sample Size Requirements. AJNR Am J Neuroradiol 28 (6): 1119–1125.